INT239474

From wiki-pain
Revision as of 03:22, 21 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.36
Pain Relevance 0.45

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

peptidase activity (ACR) DNA binding (ACR) protein complex (ACR)
ACR (Homo sapiens)
Ifx (Mus musculus)
Pain Link Frequency Relevance Heat
Infliximab 59 100.00 Very High Very High Very High
Adalimumab 52 90.96 High High
Rheumatism 4 82.28 Quite High
rheumatoid arthritis 26 64.80 Quite High
methotrexate 4 29.20 Quite Low
antagonist 5 5.00 Very Low Very Low Very Low
cINOD 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 9 93.36 High High
Rheumatic Diseases 4 82.28 Quite High
Rheumatoid Arthritis 26 64.80 Quite High
Mycobacterial Infection 12 59.12 Quite High
Lymphatic System Cancer 4 5.00 Very Low Very Low Very Low
Infection 4 5.00 Very Low Very Low Very Low
Cough 2 5.00 Very Low Very Low Very Low
Demyelinating Disease 2 5.00 Very Low Very Low Very Low
B-cell Lymphoma 2 5.00 Very Low Very Low Very Low
INFLAMMATION 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
At Week 16, ACR20 was 29%, 60%, and 40% among those patients who had no response, loss of response, and intolerance to IFX, respectively (Table 3).
ACR20 Binding (intolerance) of IFX associated with infliximab
1) Confidence 0.02 Published 2008 Journal Clin Rheumatol Section Body Doc Link PMC2468311 Disease Relevance 0.36 Pain Relevance 0.45

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox